Anupam Rasayan India Limited
Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals
Key metrics
Price as of 2026-07-17
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 480 Cr | 386 Cr | 392 Cr | 296 Cr | 401 Cr | 254 Cr | 294 Cr | 390 Cr | 500 Cr | 486 Cr | 731 Cr | 512 Cr |
| Operating expenses (approx.) | 363 Cr | 285 Cr | 285 Cr | 216 Cr | 308 Cr | 201 Cr | 214 Cr | 266 Cr | 356 Cr | 362 Cr | 596 Cr | 385 Cr |
| EBITDA | 117 Cr | 101 Cr | 107 Cr | 79 Cr | 93 Cr | 53 Cr | 80 Cr | 124 Cr | 144 Cr | 124 Cr | 136 Cr | 127 Cr |
| OPM % | 24.4% | 26.2% | 27.4% | 26.8% | 23.1% | 20.9% | 27.4% | 31.9% | 28.9% | 25.6% | 18.6% | 24.9% |
| Other income | 24 Cr | 12 Cr | 3 Cr | 2 Cr | 12 Cr | 6 Cr | 2 Cr | -4 Cr | 6 Cr | 5 Cr | 8 Cr | 2 Cr |
| Interest | 20 Cr | 18 Cr | 20 Cr | 25 Cr | 26 Cr | 22 Cr | 27 Cr | 32 Cr | 31 Cr | 36 Cr | 36 Cr | 35 Cr |
| Depreciation | 19 Cr | 19 Cr | 20 Cr | 20 Cr | 21 Cr | 21 Cr | 22 Cr | 29 Cr | 31 Cr | 31 Cr | 32 Cr | 34 Cr |
| Profit before tax | 103 Cr | 77 Cr | 71 Cr | 36 Cr | 58 Cr | 16 Cr | 34 Cr | 59 Cr | 88 Cr | 63 Cr | 76 Cr | 60 Cr |
| Tax % | 29.3% | 32.4% | 31.1% | 27.5% | 30.1% | 24.7% | 10.0% | 8.9% | 28.6% | 22.9% | 24.3% | -1.1% |
| Net profit | 73 Cr | 52 Cr | 49 Cr | 26 Cr | 40 Cr | 12 Cr | 31 Cr | 54 Cr | 63 Cr | 48 Cr | 57 Cr | 61 Cr |
| EPS (₹) | ₹7.00 | ₹4.86 | ₹3.78 | ₹1.70 | ₹2.81 | ₹0.36 | ₹1.51 | ₹2.57 | ₹4.06 | ₹3.10 | ₹3.93 | ₹4.31 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|
| Sales | 811 Cr | 1,066 Cr | 1,602 Cr | 1,475 Cr | 1,437 Cr | Sign in for TTM |
| Operating expenses (approx.) | 617 Cr | 769 Cr | 1,171 Cr | 1,094 Cr | 1,036 Cr | Sign in for TTM |
| EBITDA | 194 Cr | 297 Cr | 431 Cr | 381 Cr | 401 Cr | Sign in for TTM |
| OPM % | 23.9% | 27.9% | 26.9% | 25.8% | 27.9% | Sign in for TTM |
| Other income | 26 Cr | 15 Cr | 9 Cr | 30 Cr | 11 Cr | Sign in for TTM |
| Interest | 69 Cr | 31 Cr | 63 Cr | 89 Cr | 112 Cr | Sign in for TTM |
| Depreciation | 52 Cr | 60 Cr | 71 Cr | 80 Cr | 102 Cr | Sign in for TTM |
| Profit before tax | 100 Cr | 221 Cr | 306 Cr | 242 Cr | 198 Cr | Sign in for TTM |
| Tax % | 29.7% | 31.5% | 29.7% | 30.7% | 19.1% | Sign in for TTM |
| Net profit | 70 Cr | 152 Cr | 217 Cr | 167 Cr | 160 Cr | Sign in for TTM |
| EPS (₹) | ₹8.56 | ₹15.22 | ₹20.91 | ₹11.89 | ₹8.50 | Sign in for TTM |
| Dividend payout % | — | 6.6% | 11.3% | 15.7% | 8.4% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Equity capital | 100 Cr | 100 Cr | 107 Cr | 110 Cr | 110 Cr |
| Reserves | 70 Cr | 1,627 Cr | 2,265 Cr | 2,651 Cr | 2,740 Cr |
| Borrowings | 387 Cr | 796 Cr | 788 Cr | 1,020 Cr | 1,318 Cr |
| Other liabilities | 338 Cr | 368 Cr | 482 Cr | 651 Cr | 869 Cr |
| Total liabilities | 2,298 Cr | 2,891 Cr | 3,778 Cr | 4,602 Cr | 5,269 Cr |
| Fixed assets (net) | 1,103 Cr | 1,191 Cr | 1,280 Cr | 1,357 Cr | 2,038 Cr |
| CWIP | 43 Cr | 44 Cr | 120 Cr | 609 Cr | 216 Cr |
| Investments | 0.02 Cr | 149 Cr | 67 Cr | 67 Cr | 9 Cr |
| Other assets | 1,126 Cr | 1,451 Cr | 2,126 Cr | 2,229 Cr | 2,575 Cr |
| Total assets | 2,298 Cr | 2,891 Cr | 3,778 Cr | 4,602 Cr | 5,269 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Cash from operating activity | — | -171 Cr | 292 Cr | 59 Cr | -30 Cr |
| Cash from investing | — | -412 Cr | -523 Cr | -392 Cr | -330 Cr |
| Cash from financing | — | 384 Cr | 371 Cr | 395 Cr | 223 Cr |
| Net cash flow | — | -199 Cr | 140 Cr | 62 Cr | -137 Cr |
| Free cash flow (OCF − Capex) | — | -318 Cr | 71 Cr | -657 Cr | -440 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| ROCE % | 7.2% | 9.4% | 10.9% | 7.6% | 6.8% |
| ROE % | 4.5% | 8.8% | 7.2% | 4.4% | 3.0% |
| Debtor days | 92 | 96 | 94 | 143 | 186 |
| Inventory days | 382 | 454 | 442 | 556 | 564 |
| Days payable | 155 | 120 | 153 | 219 | 224 |
| Cash conversion cycle | 319 | 430 | 383 | 480 | 526 |
| Debt / equity | 0.25 | 0.46 | 0.33 | 0.37 | 0.46 |
| Current ratio | 2.65 | 2.43 | 2.60 | 1.69 | 1.42 |
| Net debt / EBITDA | 0.75 | 2.54 | 1.39 | 2.02 | 3.01 |
Compare with peers
Loading peers…